blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1228763

EP1228763 - Multiparticulate formulations of lithium salts for once-a-day administration [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  27.01.2012
Database last updated on 11.09.2024
Most recent event   Tooltip27.01.2012Application deemed to be withdrawnpublished on 29.02.2012  [2012/09]
Applicant(s)For all designated states
Valpharma S.A.
Via Ranco, 112
47031 Serravalle / SM
[2002/32]
Inventor(s)01 / Valducci, Roberto
Via del Sole 4
47039 Savignano sul Rubicone (Forli) / IT
02 / Alighieri, Tiziano
Via Casadei Flavia 24
47900 Rimini / IT
03 / Avanessian, Serozh
Via Lagomaggio 73/a
47900 Rimini / IT
 [2002/32]
Representative(s)Negrini, Elena
Agazzani & Associati S.r.l. Studio Ing. Giampaolo Agazzani Via dell'Angelo Custode 11/6
40141 Bologna / IT
[N/P]
Former [2002/32]Negrini, Elena
Agazzani & Associati S.r.l. & Studio Ing. Giampaolo Agazzani, Via dell'Angelo Custode 11/6
40141 Bologna / IT
Application number, filing date02002523.503.02.2002
[2002/32]
Priority number, dateIT2001MI0022005.02.2001         Original published format: IT MI010220
[2002/32]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1228763
Date:07.08.2002
Language:EN
[2002/32]
Search report(s)(Supplementary) European search report - dispatched on:EP16.05.2002
ClassificationIPC:A61K33/00, A61K9/50, A61K9/28
[2002/32]
CPC:
A61K33/00 (EP,US); A61K9/2866 (EP,US); A61K9/5026 (EP,US);
A61K9/5042 (EP,US); A61K9/5047 (EP,US); A61K9/5084 (EP,US);
A61P25/18 (EP); A61P25/24 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2002/32]
Extension statesAL07.02.2003
LT07.02.2003
LV07.02.2003
MK07.02.2003
RO07.02.2003
SI07.02.2003
TitleGerman:Multipartikuläre Formulierungen von Lithiumsalzen zur einmal täglichen Verabreichung[2002/32]
English:Multiparticulate formulations of lithium salts for once-a-day administration[2002/32]
French:Formulations multiparticulaires à base de sels de lithium pour une administration journaliére monodose[2002/32]
Examination procedure07.02.2003Examination requested  [2003/15]
01.04.2003Despatch of a communication from the examining division (Time limit: M04)
31.07.2003Reply to a communication from the examining division
13.01.2004Despatch of a communication from the examining division (Time limit: M04)
13.05.2004Reply to a communication from the examining division
07.10.2004Observations by third parties
18.01.2005Despatch of a communication from the examining division (Time limit: M06)
13.07.2005Reply to a communication from the examining division
01.09.2011Application deemed to be withdrawn, date of legal effect  [2012/09]
11.10.2011Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2012/09]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  01.04.2003
Fees paidRenewal fee
01.03.2004Renewal fee patent year 03
28.02.2005Renewal fee patent year 04
28.02.2006Renewal fee patent year 05
28.02.2007Renewal fee patent year 06
29.02.2008Renewal fee patent year 07
02.03.2009Renewal fee patent year 08
01.03.2010Renewal fee patent year 09
Penalty fee
Additional fee for renewal fee
28.02.201110   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]FR2244485  (ARIES ROBERT [FR]) [X] 1-6,8-12,14,16,18 * claims 1,5-7 * * page 2, line 27 - page 3, line 15 * * page 4; example 3 *;
 [A]EP0052075  (CIBA GEIGY AG [CH]) [A] 1-18 * the whole document *;
 [A]EP0396425  (KV PHARM CO [US]) [A] 1-18* the whole document *;
 [X]  - RAFIEE-TEHRANI, MORTEZA ET AL, "Formulation of controlled-release lithium carbonate tablets by a fluidized-bed technique", CHEMICAL ABSTRACTS, (19940725), vol. 121, no. 4, Database accession no. 42626, XP000363223 [X] 1-12,14-18 * abstract *
otherWO0211740
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.